Syndax Pharmaceuticals (SNDX) Earnings Date, Estimates & Call Transcripts → Never use this word on your phone (FBI could be watching) (From Paradigm Press) (Ad) Free sndx Stock Alerts $22.05 +0.19 (+0.87%) (As of 05/3/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateMay. 8Before Market OpensConfirmedActual EPS (Feb. 27) -$1.00 Missed By -$0.01 Consensus EPS (Feb. 27) -$0.99 Read Call TranscriptListen to Call Get Syndax Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for SNDX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueSNDX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SNDX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad AltimetryUrgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.Click here to access… Syndax Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($1.00)($0.91)($0.96)Q2 20242($1.04)($0.95)($1.00)Q3 20242($1.03)($0.99)($1.01)Q4 20242($1.05)($0.78)($0.92)FY 20248($4.12)($3.63)($3.88)SNDX Earnings Date and InformationSyndax Pharmaceuticals last released its quarterly earnings results on February 27th, 2024. The reported ($1.00) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.99) by $0.01. Syndax Pharmaceuticals has generated ($2.96) earnings per share over the last year (($2.96) diluted earnings per share). Earnings for Syndax Pharmaceuticals are expected to grow in the coming year, from ($3.74) to ($2.96) per share. Syndax Pharmaceuticals has confirmed that its next quarterly earnings report will be published on Wednesday, May 8th, 2024. Syndax Pharmaceuticals will be holding an earnings conference call on Wednesday, May 8th at 8:00 AM Eastern. Interested parties can register for or listen to the call.. Read More Syndax Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/8/2024Confirmed)------- 2/27/2024Q4 2023($0.99)($1.00)($0.01)($1.00)-- 11/2/2023Q3 2023($0.80)($0.73)+$0.07($0.73)--8/3/2023Q2 2023($0.73)($0.64)+$0.09($0.64)-- 5/8/2023Q1 2023($0.61)($0.59)+$0.02($0.59)--2/28/2023Q4 2022($0.64)($0.62)+$0.02($0.62)-- 11/3/2022Q3 2022($0.65)($0.58)+$0.07($0.58)-- Get the Latest News and Ratings for SNDX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Syndax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/8/2022Q2 2022($0.65)($0.62)+$0.03($0.62)--5/9/2022Q1 2022($0.63)($0.63)-($0.63)-- 3/1/2022Q4 2021($0.68)$1.81+$2.49$1.81-$126.58 million 11/15/2021Q3 2021($0.64)($0.40)+$0.24($0.40)-$12.38 million 8/9/2021Q2 2021($0.74)($0.44)+$0.30($0.44)$0.50 million$0.38 million 5/11/2021Q1 2021($0.63)($0.54)+$0.09($0.54)$0.50 million$0.38 million Syndax Pharmaceuticals Earnings - Frequently Asked Questions When is Syndax Pharmaceuticals's earnings date? Syndax Pharmaceuticals has confirmed that its next quarterly earnings data will be published on Wednesday, May 8th, 2024. Learn more on SNDX's earnings history. Did Syndax Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Syndax Pharmaceuticals (NASDAQ:SNDX) missed the analysts' consensus estimate of ($0.99) by $0.01 with a reported earnings per share (EPS) of ($1.00). Learn more on analysts' earnings estimate vs. SNDX's actual earnings. How can I listen to Syndax Pharmaceuticals's earnings conference call? The conference call for Syndax Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Syndax Pharmaceuticals's conference call transcript? The conference call transcript for Syndax Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Syndax Pharmaceuticals generate each year? Syndax Pharmaceuticals (NASDAQ:SNDX) has a recorded annual revenue of $139.71 million. How much profit does Syndax Pharmaceuticals generate each year? Syndax Pharmaceuticals (NASDAQ:SNDX) has a recorded net income of -$209.36 million. SNDX has generated -$2.96 earnings per share over the last four quarters. What is Syndax Pharmaceuticals's EPS forecast for next year? Syndax Pharmaceuticals's earnings are expected to grow from ($3.74) per share to ($2.96) per share in the next year. More Earnings Resources from MarketBeat Related Companies: AGIO Earnings Results SDGR Earnings Results CPRX Earnings Results GPCR Earnings Results AMRX Earnings Results GERN Earnings Results SUPN Earnings Results AVDL Earnings Results HRMY Earnings Results GLPG Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Apple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings? This page (NASDAQ:SNDX) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersCould Your Accounts Be Frozen?Allegiance GoldAutomatic Income (from home)Awesomely, LLCUrgent Nvidia WarningAltimetryForget Nvidia. This is the future of AIPorter & CompanyHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceThe asset beating inflation by 4xColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Syndax Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
